Rowley, S.D.; Albitar, M.; Baker, M.F.; Ali, A.; Kaur, S.; Suh, H.C.; Goy, A.; Donato, M.L.
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies. Cancers 2025, 17, 625.
https://doi.org/10.3390/cancers17040625
AMA Style
Rowley SD, Albitar M, Baker MF, Ali A, Kaur S, Suh HC, Goy A, Donato ML.
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies. Cancers. 2025; 17(4):625.
https://doi.org/10.3390/cancers17040625
Chicago/Turabian Style
Rowley, Scott D., Maher Albitar, Melissa F. Baker, Alaa Ali, Sukhdeep Kaur, Hyung C. Suh, Andre Goy, and Michele L. Donato.
2025. "cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies" Cancers 17, no. 4: 625.
https://doi.org/10.3390/cancers17040625
APA Style
Rowley, S. D., Albitar, M., Baker, M. F., Ali, A., Kaur, S., Suh, H. C., Goy, A., & Donato, M. L.
(2025). cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies. Cancers, 17(4), 625.
https://doi.org/10.3390/cancers17040625